Finally, the AKAP13 Rho-GEF and PKD-binding domains might be required for signaling through compensatory pathways, including additional adrenergic or angiotensin pathways, activated during cardiac hypertrophy. Here, AKAP13 is linked to cardiac hypertrophy.